Senior Director, Field HEOR

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Rev Med Health Economics & Outcomes Research (HEOR) and Real World Evidence (RWE) is expanding their field-based HEOR organization. The Field HEOR team works collaboratively with in-house teams to generate evidence-based solutions to optimize patient access while also integrating with in-field access teams to effectively translate HEOR evidence to targeted payer & provider customers. This position will report to the Executive Director of HEOR Payer and HTA Strategy. The Senior Director, Field HEOR will be accountable for working collaboratively with the HEOR TA lead conducting customer centric research across an assets lifecyle that demonstrates the value of Rev Med’s products. The customer facing responsibilities of this role includes partnering with field access teams, translating HEOR evidence to population level decision makers, cultivating research partnerships, developing relationships with external HEOR researchers and establishing evidentiary solutions to solve access challenges. The Senior Director of Field HEOR is a critical member of the HEOR organization to direct evidentiary strategies that are customer and patient centric. This is an exceptional opportunity to contribute to the advancement of healthcare by providing evidence that can shape the future of patient care in Oncology. Ideal candidate will be located in the Mid-Atlantic, South, to Southeast. Builds strong collaborative relationships with in-house HEOR researchers and medical / commercial matrix team members to co-lead the development of strong customer centric research strategies (representing ~60% of time): Leverages deep understanding of the access environment to co-lead with HEOR Executive Directors the development of integrated evidence plans and execution of RWE research across the lifecycle of Rev Meds assets. Partners closely with senior leadership on the development and execution of strategic HEOR strategy and team direction. Develops and executes HEOR/RWE strategy and tactics with quality and in alignment with agreed upon timing. Provides RWE & access expertise & leadership through appropriate cross-functional teams aligned to our therapeutic areas. Influences HEOR and Medical Affairs leadership to ensure critical RWE / access insights are communicated and embedded into our appropriate TA strategies. Effectively presents research findings to internal stakeholders to improve internal decision making and to promote wider adoption of research findings. Leads enterprise initiatives that solve for access, reimbursement and HTA challenges. Develops value evidence materials (i.e., proactive, reactive slide decks, models, etc...) for external facing teams to support access challenges. Integrates into Rev Meds in-field access teams as a core matrix team member to shape the development and execution of key account strategies including (representing ~40% of time): Functions as an HEOR expert to effectively translate complex HEOR evidence and payer-value propositions to both population level decision makers (i.e, U.S. payers, IDNs, GPOs, guideline developers, academicians, and other key stakeholders) and in-field teams to maximize access. Leverages existing relationships and cultivates new rel…